alexa How To Leverage And Protect IPR For Biosimilars
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars
October 27-29, 2014 Hyderabad International Convention Centre, Hyderabad, India

Balu Gupta
Accepted Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.015
Abstract
Although new biologic-based drugs are becoming increasingly important in addressing a variety of disease conditions, biosimilars based on such prominent drugs are slowly making their way into regulatory approvals. This presentation looks at a variety of options that this marked area of new technology has created in protecting invaluable intellectual property rights (IPR) and also, how this new technology provides avenues to enter into new business opportunities that address unmet societal needs. The presentation will also look briefly into the creation of IPR and ways in which to capitalize it under current regulatory practices in the US with some case studies.
Biography
Balu Gupta is a seasoned patent attorney and is currently the in-house Patent Counsel at Promerus LLC. Before joining Promerus LLC, he held a variety of positions of increasing responsibilities in his many years of illustrious career at Sanofi. Over the years at Sanofi, he headed both the Global Immuno-inflammation and CNS/Oncology patent groups and was responsible for all patent and regulatory matters. He holds a doctorate degree in organic chemistry from University of Southern California (Nobel Laureate, George Olah as Thesis Adviser) and a law degree from Seton Hall University. Balu is admitted to practice law in New Jersey and Texas and is a registered patent attorney. Prior to entering his legal career, he was a bench chemist for about ten years, holding about 30 patents, and has successfully prosecuted over 330 US patents.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords